Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia

Patient Education and Counseling

Volumn 83, Issue 3, 2011, Pages 325-335

  Fuller, Joanne M ^a   Wong, Keith K ^a   Krass, Ines ^a   Grunstein, Ronald ^a   Saini, Bandana ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Behavior change; Pharmacy; Sleep disorders; Sleep health

Indexed keywords

ALCOHOL; CAFFEINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; AWARENESS; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT INFORMATION; PATIENT REFERRAL; PHARMACIST; PRIORITY JOURNAL; QUESTIONNAIRE; RISK MANAGEMENT; SCREENING TEST; SLEEP DISORDER; VERBALIZATION;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; COMMUNITY PHARMACY SERVICES; COUNSELING; EDUCATION, PHARMACY, CONTINUING; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PREVENTIVE HEALTH SERVICES; PROFESSIONAL ROLE; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUESTIONNAIRES; REFERRAL AND CONSULTATION; SLEEP DISORDERS; YOUNG ADULT;

EID: 79958768991     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2011.05.004     Document Type: Article

References (68)

1. Access Economics Pty Ltd. Wake up Australia: the value of healthy sleep, 2004. Report to Sleep Health Australia; October 2004.
2. Institute of Medicine of the National and Academies Sleep disorders and sleep deprivation: an unmet public health problem 2006.
3. Ram S., Seirawan H., Kumar S.K., Clark G.T. Prevalence and impact of sleep disorders and sleep habits in the United States. Sleep Breath 2010, 14:63-70.
4. Santos-Silva R., Bittencourt L.R., Pires M.L., de Mello M.T., Taddei J.A., Benedito-Silva A.A., et al. Increasing trends of sleep complaints in the city of Sao Paulo, Brazil. Sleep Med 2010, 11:520-524.
5. Chasens E.R., Twerski S.R., Yang K., Umlauf M.G. Sleepiness and health in midlife women: results of the National Sleep Foundation's 2007 Sleep in America poll. Behav Sleep Med 2010, 8:157-171.
6. Pigeon W.R. Diagnosis, prevalence, pathways, consequences & treatment of insomnia. Indian J Med Res 2010, 131:321-332.
7. Natarajan R. Review of periodic limb movement and restless leg syndrome. J Postgrad Med 2010, 56:157-162.
8. Bartlett D.J., Marshall N.S., Williams A., Grunstein R.R. Predictors of primary medical care consultation for sleep disorders. Sleep Med 2008, 9:857-864.
9. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
10. Young T., Evans L., Finn L., Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997, 20:705-706.
11. Hillman D.R., Murphy A.S., Pezzullo L. The economic cost of sleep disorders. Sleep 2006, 29:299-305.
12. Moller H.J. Assessing comorbidity and functional impact of sleep disorders. J Psychosom Res 2009, 67:107-108.
13. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Javier Nieto F., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163:19-25.
14. Seicean S., Kirchner H.L., Gottlieb D.J., Punjabi N.M., Resnick H., Sanders M., et al. Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care 2008, 31:1001-1006.
15. Agrawal V., Vanhecke T.E., Rai B., Franklin B.A., Sangal R.B., McCullough P.A. Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron Clin Pract 2009, 113:140-147.
16. Sarsour K., Van Brunt D.L., Johnston J.A., Foley K.A., Morin C.M., Walsh J.K. Associations of nonrestorative sleep with insomnia, depression, and daytime function. Sleep Med 2010, 11:965-972.
17. Marshall N.S., Wong K.K., Liu P.Y., Cullen S.R., Knuiman M.W., Grunstein R.R. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008, 31:1079-1085.
18. Marshall N.S., Wong K.K., Phillips C.L., Liu P.Y., Knuiman M.W., Grunstein R.R. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?. J Clin Sleep Med 2009, 5:15-20.
19. Bartlett D.J., Marshall N.S., Williams A., Grunstein R.R. Sleep health New South Wales: chronic sleep restriction and daytime sleepiness. Intern Med J 2008, 38:24-31.
20. Roth T. A physiologic basis for the evolution of pharmacotherapy for insomnia. J Clin Psychiatry 2007, 5:13-18.
21. Earley C.J., Silber M.H. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med 2010, 11:807-815.
22. Olsen S., Smith S., Oei T.P. Adherence to continuous positive airway pressure therapy in obstructive sleep apnoea sufferers: a theoretical approach to treatment adherence and intervention. Clin Psychol Rev 2008, 28:1355-1371.
23. Weaver T., Sawyer A. Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions. Indian J Med Res 2010, 131:245-258.
24. Ebben M.R., Spielman A.J. Non-pharmacological treatments for insomnia. J Behav Med 2009, 32:244-254.
25. Richards D., Bartlett D.J., Wong K., Malouff J., Grunstein R.R. Increased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial. Sleep 2007, 30:635-640.
26. Yang C.M., Lin S.C., Hsu S.C., Cheng C.P. Maladaptive sleep hygiene practices in good sleepers and patients with insomnia. J Health Psychol 2010, 15:147-155.
27. Espie C.A., MacMahon K.M., Kelly H.L., Broomfield N.M., Douglas N.J., Engleman H.M., et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep 2007, 30:574-584.
28. Buysse D.J. Chronic insomnia. Am J Psychiatry 2008, 165:678-686.
29. Vinson D.C., Manning B.K., Galliher J.M., Dickinson L.M., Pace W.D., Turner B.J. Alcohol and sleep problems in primary care patients: a report from the AAFP National Research Network. Ann Fam Med 2010, 8:484-492.
30. Htoo A., Talwar A., Feinsilver S.H., Greenberg H. Smoking and sleep disorders. Med Clin North Am 2004, 88:1575-1591.
31. Charles J., Harrison C., Britt H. Insomnia. Aust Fam Physician 2009, 38:283.
32. Morin C.M., Bootzin R.R., Buysse D.J., Edinger J.D., Espie C.A., Lichstein K.L. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004). Sleep 2006, 29:1398-1414.
33. Morgenthaler T., Kramer M., Alessi C., Friedman L., Boehlecke B., Brown T., et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep 2006, 29:1415-1419.
34. Montgomery P., Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev 2003, CD003161.
35. Benca R.M. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 2005, 56:332-343.
36. Kippist C., Wong K., Bartlett D.J., Saini B. How do pharmacists respond to complaints of acute insomnia? A simulated patient study. Int J Clin Pharm 2011, 33:237-245.
37. Hollingworth S., Siskind D. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf 2010, 19:280-288.
38. National Prescribing Service. Management options to maximise sleep NPS Education Programme for Prescribers; 2011 [accessed 10 December, 2010, at]. http://www.nps.org.au/.
39. The Pharmacy Guild of Australia, ACT, Australia. The Guild Digest; 2009 [accessed 10 December, 2010, at]. http://www.guild.org.au/.
40. Mc Namara K.P., George J., O'Reilly S.L., Jackson S.L., Peterson G.M., Howarth H., et al. Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study. BMC Health Serv Res 2010, 10.
41. Sinclair H.K., Bond C.M., Stead L.F. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev 2010, 11:11.
42. Tran A., Fuller J.M., Wong K.K., Grunstein R.R., Krass I., Saini B. The devleopment of a sleep disorder screening program in Australian community pharmacies. Pharm World Sci 2009, 31:473-480.
43. Hersberger K., Renggli V., Nirkko A., Mathis J., Schwegler K., Bloch K. Screening for sleep disorders in community pharmacies-evaluation of a campaign in Switzerland. J Clin Pharm Ther 2006, 31:35-41.
44. The Pharmaceutical Society of Australia National competency standards framework for pharmacists in Australia 2010.
45. Schwarzer R., Renner B. Social-cognitive predictors of health behavior: action self-efficacy and coping self-efficacy. Health Psychol 2000, 19:487-495.
46. Absetz P., Valve R., Oldenburg B., Heinonen H., Nissinen A., Fogelholm M., et al. Type 2 diabetes prevention in the "real world": one-year results of the GOAL implementation trial. Diabetes Care 2007, 30:2465-2470.
47. Laatikainen T., Dunbar J.A., Chapman A., Kilkkinen A., Vartiainen E., Heistaro S., et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health 2007, 7.
48. Tze-Min Ang K., Saini B., Wong K. Sleep health awareness in pharmacy undergraduates and practising community pharmacists. J Clin Pharm Ther 2008, 33:641-652.
49. Sateia M.J., Reed V.A., Christian Jernstedt G. The Dartmouth sleep knowledge and attitude survey: development and validation. Sleep Med 2005, 6:47-54.
50. Johns M.W. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991, 14:540-545.
51. Bastein C., Vallieres A., Morin C. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001, 2:297-307.
52. Walters A.S., LeBrocq C., Dhar A., Hening W., Rosen R., Allen R.P., et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 2003, 42:121-132.
53. Maislin G., Pack A., Kribbs N., Smith P., Schwartz A., Kline L., et al. A survey screen for prediction of sleep apnea. Sleep 1995, 18:158-166.
54. Stepanski E.J., Wyatt J.K. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev 2003, 7:215-225.
55. Westbury J.L., Jackson S., Peterson G.M. Psycholeptic use in aged care homes in Tasmania, Australia. J Clin Pharm Ther 2010, 35:189-193.
56. James J, Kristjánsson A, Sigfúsdóttir I. Adolescent substance use, sleep, and academic achievement: evidence of harm due to caffeine. J Adolesc, in press.
57. Ohayon M.M., Bader G. Prevalence and correlates of insomnia in the Swedish population aged 19-75 years. Sleep Med 2010, 11:980-986.
58. Reinberg A., Touitou Y., Lewy H., Mechkouri M. Habitual moderate alcohol consumption desynchronizes circadian physiologic rhythms and affects reaction-time performance. Chronobiol Int 2010, 27:1930-1942.
59. Armour C., Bosnic-Anticevich S., Brillant M., Burton D., Emmerton L., Krass I., et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007, 62:496-502.
60. Saini B., Filipovska J., Bosnic-Anticevich S., Taylor S., Krass I., Armour C. An evaluation of a community pharmacy-based rural asthma management service. Aust J Rural Health 2008, 16:100-108.
61. Smith L., Bosnic-Anticevich S.Z., Mitchell B., Saini B., Krass I., Armour C. Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Soc Sci Med 2007, 64:1501-1511.
62. Antic N.A., Buchan C., Esterman A., Hensley M., Naughton M.T., Rowland S., et al. A randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apnea. Am J Respir Crit Care Med 2009, 179:501-508.
63. Espie C.A. "Stepped care": a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 2009, 32:1549-1558.
64. Friedman L., Benson K., Noda A. An actigraphic comparison of sleep restriction and sleep hygiene treatments for insomnia in older adults. J Geriatr Psychiatry Neurol 2000, 13:17-27.
65. McCarney R., Warner J., Iliffe S., van Haselen R., Griffin M., Fisher P. The Hawthorne effect: a randomised controlled trial. BMC Med Res Methodol 2007, 7:30.
66. Bartlett D.J., Wong K., Richards D., Moy E., Espie C.A., Cistulli P., et al. A randomised controlled trial comparing enhanced behavioural intervention with standard education on CPAP adherence. Sleep Biol Rhythms 2010, 8:A76.
67. Smith L, Nguyen T, Seeto C, Saini B, Brown L. The role of non-clinicians in a goal setting model for the management of allergic rhinitis in community pharmacy settings. Patient Educ Couns, in press. doi:10.1016/j.pec.2010.10.003.
68. Scales R., Miller J., Burden R. Why wrestle when you can dance? Optimizing outcomes with motivational interviewing. J Am Pharm Assoc 2003, 43:S46-S47.